Stage 3 T-cell lymphoma is an aggressive form of non-Hodgkin's lymphoma (NHL) that originates in mature T-cells, a type of white blood cell. It is a type of cancer that begins in the lymphocytes, a type of white blood cell that plays a role in the body's immune system. The lymphoma cells can grow and spread to other parts of the body, including the lymph nodes, bone marrow, and other organs.
Stage 3 T-cell lymphoma is an advanced form of NHL that is characterized by the spread of the cancer to the lymph nodes and other organs, such as the bone marrow, spleen, liver, and lungs. It is the most serious type of T-cell lymphoma and is usually considered incurable.
Symptoms of Stage 3 T-cell lymphoma may include enlarged lymph nodes, fever, night sweats, weight loss, fatigue, and itching. Treatment for Stage 3 T-cell lymphoma typically involves a combination of chemotherapy, radiation, and/or immunotherapy.
Patients with Stage 3 T-cell lymphoma have a poor prognosis and often face a high risk of recurrence. The survival rate for this form of lymphoma is low, as it is often resistant to treatment. However, early diagnosis and treatment can improve the chances of long-term survival and remission.